Recent Posts
- Octuplets mom Nadya Suleman settles her workers’ comp case
- Lawsuit alleges UMC misclassified patients, overcharged millions
- Stabbing victim files civil suit against family
- Potentially deadly ice cream recalled
- Fatal I-75 crash in 2009 spawns lawsuit against Collier teacher
- Spencer Reed Group to Settle EEOC Race and Age Discrimination Lawsuit
- Sickened September 11 workers get revised settlement
- Metro sports giants clash in court
- Wrongful death lawsuit filed against 4 New Orleans cops in Henry Glover case
- Starwatch consumer | BMW, VW issue recalls
- Wrigley Settles False-Ad Class Action For $6M
- New sex abuse suit filed against Los Angeles Archdiocese
- Police, fire unions sue Baltimore over pensions
- Woman falls asleep on United flight, wakes up alone after plane lands
- Carradine’s wife sues film company
Archived Posts
- June 2010 (39)
- May 2010 (27)
- April 2010 (57)
- March 2010 (168)
- February 2010 (144)
- January 2010 (119)
- December 2009 (8)
- November 2009 (165)
- October 2009 (1)
- June 2009 (29)
- April 2009 (61)
- March 2009 (140)
- February 2009 (156)
- January 2009 (151)
- December 2008 (143)
- November 2008 (113)
- October 2008 (192)
- September 2008 (88)
- August 2008 (8)
- July 2008 (29)
Blogroll
Pages
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Jun | ||||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | |||
Meta
Genentech Withdraws Psoriasis Drug Linked to Brain Infections
April 10, 2009
Genentech Inc. began pulling its psoriasis treatment Raptiva from the U.S. market because of the drug’s link to a rare, fatal brain disorder that has troubled at least four other medicines.
Genentech, the biotechnology company acquired last month by Swiss drugmaker Roche Holding AG, has told doctors not to write prescriptions for new patients as part of a phased withdrawal of Raptiva to be completed by June 8, the South San Francisco-based company said yesterday in a statement. About 2,000 U.S. patients may be taking Raptiva, Genentech said
The decision to withdraw the drug, which generated $108 million in U.S. sales for Genentech last year, came after three patients were diagnosed since October with the brain infection progressive multifocal leukoencephalopathy, two of whom died, said Tara Cooper, a Genentech spokeswoman. The risk of PML, which causes irreversible brain damage, outweighed Raptiva’s benefits in controlling psoriasis, the company concluded.
Read Article: Bloomberg
Posted By: Phoenix DUI Attorney
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL